0000899243-20-030323.txt : 20201103
0000899243-20-030323.hdr.sgml : 20201103
20201103200424
ACCESSION NUMBER: 0000899243-20-030323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201103
FILED AS OF DATE: 20201103
DATE AS OF CHANGE: 20201103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vavricka John
CENTRAL INDEX KEY: 0001829630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39661
FILM NUMBER: 201284916
MAIL ADDRESS:
STREET 1: C/O ATEA PHARMACEUTICALS, INC.
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001593899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460574869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
STREET 2: 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-204-8109
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
STREET 2: 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-03
0
0001593899
Atea Pharmaceuticals, Inc.
AVIR
0001829630
Vavricka John
125 SUMMER STREET
BOSTON
MA
02110
0
1
0
0
Chief Commercial Officer
Common Stock
2020-11-03
4
C
0
82508
A
82508
I
Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust
Series B Convertible Preferred Stock
2020-11-03
4
C
0
82508
D
Common Stock
82508
0
I
Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust
The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.
/s/ Andrea Corcoran, attorney-in-fact for John Vavricka
2020-11-03